Literature DB >> 33478398

Predictors of cardiac involvement and survival in patients with primary systemic light-chain amyloidosis: roles of the clinical, chemical, and 3-D speckle tracking echocardiography parameters.

Changhui Lei1, Xiaoli Zhu1, David H Hsi2, Jing Wang1, Lei Zuo1, Shengjun Ta3, Qianli Yang1, Lei Xu1, Xueli Zhao1, Yan Wang4, Shiren Sun5, Liwen Liu6.   

Abstract

BACKGROUND: Light-chain (AL) amyloidosis is the most common type of systemic amyloidosis with poor prognosis. Currently, the predictors of cardiac involvement and prognostic staging systems are primarily based on conventional echocardiography and serological biomarkers. We used three-dimensional speckle tracking echocardiography (STE-3D) measurements of strain, hypothesizing that it could detect cardiac involvement and aid in prediction of mortality.
METHODS: We retrospectively analysed 74 consecutive patients with biopsy-proven AL amyloidosis. Among them, 42 showed possible cardiac involvement and 32 without cardiac involvement. LV global longitudinal strain (GLS), global radial strain, global circumferential strain and global area strain (GAS) measurements were obtained.
RESULTS: The GLS and GAS were considered significant predictors of cardiac involvement. The cut-off values discriminating cardiac involvement were 16.10% for GLS, 32.95% for GAS. During the median follow-up of 12.5 months (interquartile range 4-25 months), 20 (27%) patients died. For the Cox proportional model survival analysis, heart rate, cardiac troponin T, NT-proBNP levels, E/e', GLS, and GAS were univariate predictors of death. Multivariate Cox model showed that GLS ≤ 14.78% and cardiac troponin T ≥ 0.049 mg/l levels were independent predictors of survival.
CONCLUSIONS: STE-3D measurements of LV myocardial mechanics could detect cardiac involvement in patients with AL amyloidosis; GLS and cardiac biomarkers can provided prognostic information for mortality prediction.

Entities:  

Keywords:  Biomarkers; Cardiac amyloidosis; Strain imaging; Three-dimensional speckle tracking echocardiography

Year:  2021        PMID: 33478398      PMCID: PMC7819214          DOI: 10.1186/s12872-021-01856-3

Source DB:  PubMed          Journal:  BMC Cardiovasc Disord        ISSN: 1471-2261            Impact factor:   2.298


  39 in total

1.  Prognosis of Light Chain Amyloidosis With Preserved LVEF: Added Value of 2D Speckle-Tracking Echocardiography to the Current Prognostic Staging System.

Authors:  Sergio Barros-Gomes; Brittney Williams; Lara F Nhola; Martha Grogan; Joseph F Maalouf; Angela Dispenzieri; Patricia A Pellikka; Hector R Villarraga
Journal:  JACC Cardiovasc Imaging       Date:  2016-09-14

2.  Independent predictors of survival in primary systemic (Al) amyloidosis, including cardiac biomarkers and left ventricular strain imaging: an observational cohort study.

Authors:  Diego Bellavia; Patricia A Pellikka; Ghormallah B Al-Zahrani; Theodore P Abraham; Angela Dispenzieri; Chinami Miyazaki; Martha Lacy; Christopher G Scott; Jae K Oh; Fletcher A Miller
Journal:  J Am Soc Echocardiogr       Date:  2010-06       Impact factor: 5.251

Review 3.  Amyloidosis: pathogenesis and new therapeutic options.

Authors:  Giampaolo Merlini; David C Seldin; Morie A Gertz
Journal:  J Clin Oncol       Date:  2011-04-11       Impact factor: 44.544

4.  Three-dimensional Speckle Tracking Echocardiography in Light Chain Cardiac Amyloidosis: Examination of Left and Right Ventricular Myocardial Mechanics Parameters.

Authors:  Jose Angel Urbano-Moral; Dakshin Gangadharamurthy; Raymond L Comenzo; Natesa G Pandian; Ayan R Patel
Journal:  Rev Esp Cardiol (Engl Ed)       Date:  2015-06-17

5.  Atrioventricular plane displacement is the major contributor to left ventricular pumping in healthy adults, athletes, and patients with dilated cardiomyopathy.

Authors:  Marcus Carlsson; Martin Ugander; Henrik Mosén; Torsten Buhre; Hakan Arheden
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-11-10       Impact factor: 4.733

Review 6.  Three-dimensional speckle-tracking echocardiography: benefits and limitations of integrating myocardial mechanics with three-dimensional imaging.

Authors:  Denisa Muraru; Alice Niero; Hugo Rodriguez-Zanella; Diana Cherata; Luigi Badano
Journal:  Cardiovasc Diagn Ther       Date:  2018-02

7.  Longitudinal myocardial function assessed by tissue velocity, strain, and strain rate tissue Doppler echocardiography in patients with AL (primary) cardiac amyloidosis.

Authors:  Jun Koyama; Patricia A Ray-Sequin; Rodney H Falk
Journal:  Circulation       Date:  2003-05-12       Impact factor: 29.690

Review 8.  Diagnosis and Treatment of Cardiac Amyloidosis Related to Plasma Cell Dyscrasias.

Authors:  Kevin M Alexander; Alessandro Evangelisti; Ronald M Witteles
Journal:  Cardiol Clin       Date:  2019-11       Impact factor: 2.213

9.  Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy.

Authors:  Holger Vogelsberg; Heiko Mahrholdt; Claudia C Deluigi; Ali Yilmaz; Eva M Kispert; Simon Greulich; Karin Klingel; Reinhard Kandolf; Udo Sechtem
Journal:  J Am Coll Cardiol       Date:  2008-03-11       Impact factor: 24.094

10.  Quantification of myocardial extracellular volume fraction in systemic AL amyloidosis: an equilibrium contrast cardiovascular magnetic resonance study.

Authors:  Sanjay M Banypersad; Daniel M Sado; Andrew S Flett; Simon D J Gibbs; Jennifer H Pinney; Viviana Maestrini; Andrew T Cox; Marianna Fontana; Carol J Whelan; Ashutosh D Wechalekar; Philip N Hawkins; James C Moon
Journal:  Circ Cardiovasc Imaging       Date:  2012-11-28       Impact factor: 7.792

View more
  3 in total

1.  The Auxiliary Role of Cardiac Magnetic Resonance Feature-Tracking Parameters in the Differentiation between Cardiac Amyloidosis and Constrictive Pericarditis.

Authors:  Sanaz Asadian; Mahta Farzin; Faezeh Tabesh; Nahid Rezaeian; Hooman Bakhshandeh; Leila Hosseini; Yaser Toloueitabar; Mohammad Mehdi Hemmati Komasi
Journal:  Cardiol Res Pract       Date:  2021-10-23       Impact factor: 1.866

Review 2.  Light Chain Amyloidosis: Epidemiology, Staging, and Prognostication.

Authors:  Kelty R Baker
Journal:  Methodist Debakey Cardiovasc J       Date:  2022-03-14

Review 3.  The Role of Echocardiogram and Cardiac Rhythm Analysis for Early Detection of Cardiac Amyloidosis.

Authors:  Elizabeth Hubert; Joyce E Dains
Journal:  J Adv Pract Oncol       Date:  2022-10-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.